Evidence map›Paper›PMID 39295607›Full record

ArticleTurkish journal of medical sciences2024

Do patients infected with human coronavirus before the COVID-19 pandemic have less risk of being infected with COVID-19?

Gamze Şanlidağ Işbilen, Ayça Aydın Uysal, Selin Yiğit, Özgür Appak, Hilal Sipahi, Gülendam Bozdayi, Arzu Sayiner, Candan Çiçek, Özlem Güzel Tunçcan, Oğuz Reşat Sipahi

Abstract read
In one paragraph

Article in Turkish journal of medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Gamze Şanlidağ IşbilenDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0000-0003-2275-5749
Ayça Aydın UysalDepartment of Medical Microbiology, Faculty of Medicine, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0000-0003-0192-7126
Selin YiğitDepartment of Medical Microbiology, School of Medicine, Division of Medical Virology, Gazi University, Ankara, Turkiye.ORCID https://orcid.org/0000-0001-7299-0822
Özgür AppakDepartment of Medical Microbiology, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkiye.ORCID https://orcid.org/0000-0003-1810-8346
Hilal SipahiBornova Directorate of Health, İzmir, Turkiye.ORCID https://orcid.org/0000-0003-0387-5171
Gülendam BozdayiDepartment of Medical Microbiology, School of Medicine, Division of Medical Virology, Gazi University, Ankara, Turkiye.ORCID https://orcid.org/0000-0002-6036-6819
Arzu SayinerDepartment of Medical Microbiology, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkiye.ORCID https://orcid.org/0000-0001-6750-2353
Candan ÇiçekDepartment of Medical Microbiology, Faculty of Medicine, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0000-0002-3486-8305
Özlem Güzel TunçcanDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Gazi University, Ankara, Turkiye.ORCID https://orcid.org/0000-0003-1611-0725
Oğuz Reşat SipahiDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0000-0002-1243-2746

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/aim: Although seasonal human coronaviruses (HCoVs) have long been recognized as respiratory tract viruses, the newly identified SARS-CoV-2 caused a pandemic associated with severe respiratory failure. We aimed to evaluate the incidence of COVID-19 infection in patients diagnosed in three tertiary teaching hospitals, both with and without prior confirmed HCoV infection, and to compare these cohorts in terms of COVID-19 contraction. Materials and methods: In our study, we examined HCoV PCR-positive cases obtained retrospectively between January 2014 and March 2020 from three University Hospital Microbiology Laboratories (Cohort 1), as well as PCR-negative patients detected in the same PCR cycle as the positive cases (Cohort 2). We also evaluated subgroups of HCoV-positive cases. Results: There was no difference in COVID-19 contraction rates between Cohort 1 and Cohort 2 (p = 0.724). When previous HCoV subgroups of COVID-19-positive patients were examined, no significant difference was found between the betacoronavirus and alphacoronavirus subgroups (p = 0.822), among the four groups (NL63, 229E, OC43, HKU-1) (p = 0.207), or between the OC43 subgroup and the other groups (p = 0.295). Conclusion: Being previously infected with HCoV did not provide protection against COVID-19 in our study group. We suggest evaluating the possible effect of previous OC43 infection on COVID-19 contraction in larger cohorts.

Indexed as

COVID-19SARS-CoV-2AdultAgedFemaleHumansIncidenceMaleMiddle AgedRetrospective StudiesTurkeyCOVID-19epidemiologyHCoVmultiplex PCROC43prevention

Identifiers

PMID39295607
PMCPMC11407371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.